The Global ST2 Biomarker Market is anticipated to gain exponential industry growth over the given forecast period of 2022-2028. Suppression of tumorigenicity 2 (ST2) is one of the biomarkers that can help measure heart failure risk to evaluate treatment options. The ST2 biomarker is a member of the interleukin-1 receptor family biomarkers. It is a strong […]
